SELGILTA Trademark

Trademark Overview

On Friday, October 14, 2016, a trademark application was filed for SELGILTA with the United States Patent and Trademark Office. The USPTO has given the SELGILTA trademark a serial number of 79199847. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, December 15, 2023. This trademark is owned by Astellas Pharma Inc.. The SELGILTA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer
selgilta

General Information

Serial Number79199847
Word MarkSELGILTA
Filing DateFriday, October 14, 2016
Status709 - CANCELLED - SECTION 71
Status DateFriday, December 15, 2023
Registration Number5211445
Registration DateTuesday, May 30, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 14, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, December 15, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstellas Pharma Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP
Party NameAstellas Pharma Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP
Party NameAstellas Pharma Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events

Event DateEvent Description
Wednesday, February 22, 2017NOTICE OF PUBLICATION
Wednesday, February 22, 2017NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 22, 2017NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Saturday, March 11, 2017NOTIFICATION PROCESSED BY IB
Thursday, January 5, 2017SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, January 10, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, January 14, 2017APPLICATION FILING RECEIPT MAILED
Wednesday, January 25, 2017ASSIGNED TO EXAMINER
Monday, January 30, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 30, 2017REGISTERED-PRINCIPAL REGISTER
Thursday, June 29, 2017GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Friday, August 6, 2021NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, March 14, 2017PUBLISHED FOR OPPOSITION
Thursday, July 6, 2017FINAL DISPOSITION PROCESSED
Thursday, July 6, 2017FINAL DISPOSITION NOTICE SENT TO IB
Friday, July 28, 2017NOTIFICATION PROCESSED BY IB
Friday, June 3, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, June 3, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 3, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 3, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, June 3, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, June 3, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 15, 2023CANCELLED SECTION 71
Friday, August 16, 2024TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Wednesday, August 28, 2024TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Saturday, June 25, 2022NEW REPRESENTATIVE AT IB RECEIVED
Wednesday, August 28, 2024INVALIDATION PROCESSED
Saturday, September 14, 2024TOTAL INVALIDATION PROCESSED BY THE IB

Related Keywords

selgilta cancer treatment preparations pharmaceutical